Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double-blind, randomized, 1-year study-Reference-Cited by-同舟云学术

Alogliptin versus glipizide monotherapy in elderly type 2 diabetes mellitus patients with mild hyperglycaemia: a prospective, double-blind, randomized, 1-year study

Published:2013-04-18 Issue:10 Volume:15 Page:906-914
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Rosenstock J.¹,Wilson C.²,Fleck P.²

Affiliation:

1. Dallas Diabetes and Endocrine Center at Medical City; Dallas; TX; USA

2. Takeda Global Research & Development Center, Inc.; Deerfield; IL; USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12102/fullpdf

Reference22 articles.

1. The burden and treatment of diabetes in elderly individuals in the U.S;Selvin;Diabetes Care,2006

2. Diabetes mellitus in older adults;Mooradian;Am J Ther,2012

3. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetologia,2012

4. Type 2 diabetes mellitus: focus on new treatments and special populations;Del Prato;Int J Clin Pract,2007

5. Management of hyperglycemia in type 2 diabetes: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2006

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of glucose-lowering medications in older people: a comprehensive systematic review and network meta-analysis of randomized controlled trials;Age and Ageing;2024-08

2. Collaboration of alogliptin and pioglitazone: a double hit on the target;Meditsinskiy sovet = Medical Council;2024-05-18

3. Encyclopaedic Review of Glipizide Pre-clinical and Clinical Status;Drug Research;2024-02-26

4. Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs;BMC Endocrine Disorders;2022-10-19

5. Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study;Diabetes & Metabolism Journal;2022-09-30